All In MedTech

FDA Clearance Tracker · P000025-S113

COMBI 40+ Cochlear Implant System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 15, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 15, 2019

Approved

Time to decision

60 days

Received Aug 16, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P000025-S113
Device name
COMBI 40+ Cochlear Implant System
Applicant
Med-El Corp.
Applicant location
Innsbruck
Received
Aug 16, 2019
Decided
Oct 15, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P000025

Device type

Device class
Class III

Every decision under product code MCM

FDA's approval statement

As written in FDA's record.

Approval of the Single-Sided Deafness and Asymmetric Hearing Loss Post-Approval Study protocol.

Source documents

Other decisions for Med-El Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.